Showing 5121-5130 of 5162 results for "".
BTL, Sciton Updates; Sun Gets PsO Real
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-btl-sciton-updates-sun-gets-pso-real/19601/BTL rolls out a small Emsculpt applicator to treat arms, thighs and calves at ASLMS. Sciton introduces JOULE X. In conjunction with Sun Pharma, the Association for Applied and Therapeutic Humor is offering strategies to help psoriasis patients navigate emotional challenges and uncomfortable psoriasiOrtho Dermatologics NDA, J&J Innovation, Consumer Credit Insights
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-ortho-dermatologics-nda-j-j-innovation-consumer-credit-insights/18395/Two-thirds of prospective patients say they would be more likely to book a procedure if they were aware of financing options. More than three-quarters of prospective patients are unaware of financing options, according to a recent survey by Zalea. In conjunction with Johnson & Johnson Consumer,Pros and Cons of DTC Advertising
https://practicaldermatology.com/topics/practice-management/pros-and-cons-of-dtc-advertising/18569/Hilary Baldwin, MD and James Q. Del Rosso, DO sit down with Derm Insider Host Neal Bhatia, MD to weigh the pros and cons of direct-to-consumer advertising on patients. They agree that if done well and with a primary focus on disease state rather than a specific drug, these ads can encourage patientsBURANE, Er:YAG Laser System by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/burane-er-yag-laser-system-by-quantel-derma/19376/BURANE / BURANE XL by Quantel Derma - The universal Er:YAG laser system with Triple Mode Technology. BURANE applies the proven wavelength of 2940 nm. BURANE XL offers the unique Triple Mode Technology with Ablation Mode, Thermal Mode (non-invasive) and a combination of both. Thus, the system is theDermWireTV: Atopic Dermatitis Pipeline Watch, a Potential New Skin Cancer Treatment; Demystifying Itch, and the Premiere of PA Perspectives
https://practicaldermatology.com/topics/practice-management/dermwiretv-atopic-dermatitis-pipeline-watch-a-potential-new-skin-cancer-treatment-demystifying-itch-and-the-premiere-of-pa-perspectives/20228/Escient Pharmaceuticals, Rapt Therapeutics, and Connect Biopharma each report positive results from early clinical studies in AD. Finnish researchers discover a potential treatment for cutaneous squamous cell carcinoma in an existing chemotherapy drug. Research out of Harvard Medical School links ecEnsuring Excellent Care Across LGBTQ and Sexual Minority Patients
https://practicaldermatology.com/topics/practice-management/ensuring-excellent-care-across-lgbtq-and-sexual-minority-patients/20077/The session on LGBTQ and sexual gender minority health covered a range of topics including both clinical care as well as terminology, structures, and framework. Klint Peebles, MD talks about the importance of providing excellent dermatologic care as patients face disparities and challenges in accessPsoriasis Risk Factors and Comorbidities
https://practicaldermatology.com/topics/psoriasis/psoriasis-risk-factors-and-comorbidities/19650/Ronald Prussick, MD outlines known risk factors for developing psoriasis, such as genetic factors, smoking, alcohol consumption, and increased BMI, and recent studies that confirm these risks. He also shares data on comorbidities, including the patients with psoriasis are more prone to pathologic fr2017 Tax Cuts and Jobs Act: What You Need to Know
https://practicaldermatology.com/topics/practice-management/2017-tax-cuts-and-jobs-act-what-you-need-to-know--vmyiwowa/18348/OJM Group principal Carole Foos, CPA provides an overview of the Tax Cuts and Jobs Act, which was signed in to law at the end of 2017. She discusses key provisions affecting individual physicians and medical practices, and offers advice to consider when planning for 2018 and beyond. Click here to reExpanding Horizons in Skin Cancer Treatment
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/expanding-horizons-in-skin-cancer-treatment/18704/In Part 2 of this episode of Derm Insider, Host Neal Bhatia asks Anisha Patel, MD and Anthony Rossi, MD about advances in skin cancer therapies. Dr. Rossi discusses how to decide on the best regimens for the type of tumor being treated, and the importance of chemoprevention. They also talk more abouBeware of International Injectables
https://practicaldermatology.com/topics/practice-management/beware-of-international-injectables/19053/Julie Woodward, MD. Associate Professor of Ophthalmology Associate Professor in Dermatology; Chief, Oculoplastic and Reconstructive Surgery Service, Duke University Medical Center, addresses the challenges that arise when patients receive unknown injectables overseas. Complications from improperly u